Su, J., Wu, Y., Wu, X., Liu, Z., Wang, Y., Li, Z., . . . Zhong, J. (2023). Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy. Alimentary Pharmacology & Therapeutics, 58(8), 842. https://doi.org/10.1111/apt.17668
Chicago Style (17th ed.) CitationSu, Jia‐Yong, Ying‐Ling Wu, Xuan‐Lin Wu, Zhen‐Xiu Liu, Yi‐Yang Wang, Zhong‐Hai Li, Jia‐Xin Luo, Kun‐Jun Wu, and Jian‐Hong Zhong. "Letter: Entecavir Versus Tenofovir on Serum Lipoprotein Levels of Hepatitis B Virus‐related Hepatocellular Carcinoma After Curative Hepatectomy." Alimentary Pharmacology & Therapeutics 58, no. 8 (2023): 842. https://doi.org/10.1111/apt.17668.
MLA (9th ed.) CitationSu, Jia‐Yong, et al. "Letter: Entecavir Versus Tenofovir on Serum Lipoprotein Levels of Hepatitis B Virus‐related Hepatocellular Carcinoma After Curative Hepatectomy." Alimentary Pharmacology & Therapeutics, vol. 58, no. 8, 2023, p. 842, https://doi.org/10.1111/apt.17668.
